Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 115

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 115
---
 intended to be, and shall not be deemed to be, illustrative or interpretative for purposes of determining whether a Material Adverse Change has occurred. Non-SolicitationObligations

| (a) | On and after the date of the Agreement, except as otherwise provided in the Agreement, the Company agreed it 
 shall not, and shall cause each of its Representatives not to, directly or indirectly:                       |

| (i) | make, solicit, assist, initiate, encourage, promote or otherwise facilitate (including by way of furnishing,                                                                                                                                            
 providing access to or disclosing information, books and records, facilities or properties of the Company or a Subsidiary of the Company or entering into any form of written or oral agreement, arrangement or understanding) any inquiry, proposal or 
 offer that constitutes or could reasonably be expected to constitute an Acquisition Proposal;                                                                                                                                                           |

| (ii) | enter into, continue or otherwise participate or engage in or otherwise facilitate any discussions or                                                                                                                                                 
 negotiations with any person (other than the Purchaser, Parent and their respective affiliates and Representatives), or otherwise cooperate in any way with, or assist or participate in, encourage or otherwise facilitate, any inquiry, proposal or 
 offer that constitutes or could reasonably be expected to constitute an Acquisition Proposal, provided that, for greater certainty, the Company may (A) communicate with any person making an unsolicited Acquisition Proposal (and such              
 person’s Representatives) for the purposes of clarifying the terms and conditions of such Acquisition Proposal and assessing the likelihood of its consummation so as to determine whether such Acquisition Proposal constitutes or could             
 reasonably be expected to constitute or lead to a Superior Proposal, (B) advise any person of the restrictions of the Agreement, and (C) advise any person making an unsolicited Acquisition Proposal that such Acquisition Proposal does not         
 constitute a Superior Proposal when the Board of Directors has so determined;                                                                                                                                                                         |

| (iii) | make a Change of Recommendation; or |

| (iv) | accept, approve, endorse, recommend or enter into, or publicly propose to accept, approve, endorse, recommend                                                             
 or enter into, any letter of intent, agreement in principle, agreement, arrangement or undertaking (other than a confidentiality and standstill agreement permitted under |

69

| the Agreement) constituting an Acquisition Proposal or requiring, or reasonably expected to cause, the Company to abandon, terminate, delay or fail to consummate, or that would otherwise impede,                                                    
 interfere or be inconsistent with, the Arrangement or any